Allergan Aesthetics to Showcase Multimodal Treatment Approach and Continued Commitment to Skin Quality at AMWC Dubai

Core Insights - Allergan Aesthetics, a subsidiary of AbbVie, will present its AA Signature™ multimodal treatment approach at the Aesthetic Anti-Aging Medicine World Congress (AMWC) in Dubai from October 1 to October 3, 2025 [1][2]. Group 1: AA Signature™ Treatment Approach - The AA Signature™ approach utilizes Allergan Aesthetics' extensive product portfolio and is supported by educational resources for healthcare professionals, addressing evolving patient needs [2][3]. - This treatment has been successfully launched in over 25 countries in 2025, with plans for further expansion [2][3]. - The methodology focuses on various patient needs, including Lift Up, Distinct Definition, and improved skin quality [2]. Group 2: Aesthetic Trends and Patient Needs - There is a global trend towards a more natural and individualized aesthetic, which the AA Signature™ approach aims to fulfill [3]. - The approach is designed to empower healthcare professionals to create tailored treatment plans, enhancing patient relationships and retention [3]. Group 3: Symposiums and Expert Sessions - The Allergan Medical Institute will host a symposium on the AA Signature™ approach, featuring a live injection demonstration and discussions on addressing patient needs [4][5]. - A separate symposium will focus on mastering skin quality through a multimodal approach, highlighting the integration of various aesthetic modalities [5][6]. Group 4: Clinical Data and Research - A significant percentage (94%) of individuals express a desire to improve their facial skin quality, indicating a strong market demand for effective aesthetic solutions [6]. - The event will showcase new clinical data and research findings related to personalized aesthetics and skin quality, furthering Allergan Aesthetics' commitment to innovation [9].